CD163 and lobular neoplasia: When evaluated in multiple independent cohorts [79,101,102,103], urinary sCD163 could discriminate between patients with active LN from patients with inactive LN or non-renal SLE, suggesting a potential use in monitoring LN disease activity (see Table 2 and Table 3 for the detailed metrics).